MiniMed to Participate in Upcoming Investor Conferences

NORTHRIDGE, Calif., Aug. 25, 2026 /CNW/ — MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that management will participate in fireside chats at the following investor conferences:

21st Annual Wells Fargo Healthcare Conference
Tuesday, September 8, 2026, at 3:00 p.m. EDT / 12:00 p.m. PDT
Management: Que Dallara, Chief Executive Officer

Bank of America Global Healthcare Conference 2026
Wednesday, September 23, 2026, at 10:55 a.m. BST / 5:55 a.m. EDT / 2:55 a.m. PDT
Management: Que Dallara, Chief Executive Officer, and Chad Spooner, EVP, Chief Financial Officer

Live webcasts and replays will be accessible on the MiniMed Investor Relations website: investors.minimed.com/events.

About MiniMed
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we’ve pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.

Any forward-looking statements are subject to risks and uncertainties such as those described in MiniMed’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

SOURCE MiniMed

Contacts: Ashley Patterson, Public Relations, +1-818-576-3025; Ryan Weispfenning, Investor Relations, +1-763-505-4626